Saiboku-to
Natural Standard Bottom Line Monograph, Copyright © 2013 (www.naturalstandard.com). Commercial distribution prohibited. This monograph is intended for informational purposes only, and should not be interpreted as specific medical advice. You should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.
Related Terms
- Content available for subscribers only.
Background
- Saiboku-to is a Japanese herbal formula that is commonly used to treat asthma. Saiboku-to has been approved by the Japanese Health Ministry for the treatment of asthma. Saiboku-to has shown to decrease asthmatic inflammation in numerous trials as compared to placebo.
- Saiboku-to contains bupleurum, hoelen, pinellia, magnolia, Asian ginseng, Asian skullcap, licorice, perilla, ginger and jujube. The combination of herbs is thought to have significant anti-inflammatory and anti-histamine effects.
Theory/Evidence
- Content available for subscribers only.
Safety
- Content available for subscribers only.
Author Information
- Content available for subscribers only.
References
Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
- Content available for subscribers only.
Natural Standard Monograph (www.naturalstandard.com)
Copyright © 2013 Natural Standard. Commercial distribution or
reproduction prohibited.
The information in this monograph is intended for informational purposes
only, and is meant to help users better understand health concerns.
Information is based on review of scientific research data, historical
practice patterns, and clinical experience. This information should not be
interpreted as specific medical advice. Users should consult with a
qualified healthcare provider for specific questions regarding therapies,
diagnosis and/or health conditions, prior to making therapeutic decisions.